Preoperative transarterial chemoembolization for laparoscopic liver resection in Child A cirrhotic patients with hepatocellular carcinoma

被引:9
|
作者
Lopez-Lopez, Victor [1 ]
Brusadin, Roberto [1 ]
Lopez-Conesa, Asuncion [1 ]
Capel, Antonio [2 ]
Navarro-Barrios, Alvaro [1 ]
Cayuela, Valentin [1 ]
Lopez-Banet, Elena [3 ]
Garzon-Arana, Alejandro [4 ]
Parrilla-Paricio, Pascual [1 ]
Robles-Campos, Ricardo [1 ]
机构
[1] IMIB ARRIXACA, Clin & Univ Hosp Virgen de la Arrixaca, Dept Gen Visceral & Transplantat Surg, Murcia, Spain
[2] IMIB, Virgen de la Arrixaca Clin & Univ Hosp, Dept Intervent Radiol, Murcia, Spain
[3] IMIB, Virgen de la Arrixaca Clin & Univ Hosp, Dept Radiol, Murcia, Spain
[4] IMIB, Virgen de la Arrixaca Clin & Univ Hosp, Dept Surg Pathol, Murcia, Spain
关键词
Transarterial chemoembolization; Hepatocellular carcinoma; Laparoscopy; Liver resection; HEPATIC RESECTION; LONG-TERM; METAANALYSIS; OUTCOMES;
D O I
10.1007/s00423-020-02056-x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose Laparoscopic liver resection (LLR) for hepatocellular carcinoma (HCC) offers better short-term results than open surgery with similar long-term results although it is technically difficult due to the risk of bleeding. Methods This study included patients with HCC in Child A cirrhosis who underwent TACE before LLR between 2009 and 2019. The primary endpoint was to analyze the intraoperative and early results of this technique. We also analyzed the long-term outcomes. Patients with and without clinically significant portal hypertension (CSPH) were compared. Results A total of 44 cirrhotic patients with HCC were included (24 CSPH and 20 non-CSPH). The Pringle maneuver was used in two cases (4.5%), mean blood losses was 100 ml (range 50-200), and three patients (6.8%) required a blood transfusion. The degree of necrosis achieved was greater than 90% in 27 patients (61.4%). At 1, 3, and 5 years, overall survival was 97.7%, 81.5%, and 63.4%, respectively, and disease-free survival was 85.2%, 52.5%, and 34.5%, respectively. There were no statistically significant differences between non-CSPH and CSPH groups regarding intraoperative, early, and long-term outcomes. Conclusion In our experience, TACE could be beneficial to perform LLR in HCC Child-Pugh A patients with and without CSPH without serious complications and similar oncological outcomes.
引用
收藏
页码:763 / 771
页数:9
相关论文
共 50 条
  • [31] Preoperative Transarterial Chemoembolization for Resectable Large Hepatocellular Carcinoma Reply
    Lau, Wan Yee
    Lai, Eric C. H.
    Wu, Meng-chao
    Zhou, Wei-ping
    ANNALS OF SURGERY, 2010, 251 (02) : 386 - 387
  • [32] Laparoscopic Liver Resection for Patients with hepatocellular Carcinoma
    Manekeller, Steffen
    ZENTRALBLATT FUR CHIRURGIE, 2018, 143 (01):
  • [33] Transarterial Chemoembolization before Liver Transplantation for Hepatocellular Carcinoma
    Luo, Ying
    Ji, Wenbing
    Shi, Xianjie
    Duan, Weidong
    Dong, Jiahong
    LIVER TRANSPLANTATION, 2011, 17 (06) : S161 - S162
  • [34] Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma
    Dong-Zhi Zhang
    Xiao-Dong Wei
    Xiao-Peng Wang
    World Journal of Gastroenterology, 2015, 21 (15) : 4635 - 4643
  • [35] Chemoembolization outcomes for hepatocellular carcinoma in cirrhotic patients with compromised liver function
    Dorn, David P.
    Bryant, Mary K.
    Zarzour, Jessica
    Smith, J. Kevin
    Redden, David T.
    Saddekni, Souheil
    Aal, Ahmed Kamel Abdel
    Gray, Stephen
    White, Jared
    Eckhoff, Devin E.
    DuBay, Derek A.
    HPB, 2014, 16 (07) : 648 - 655
  • [36] Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma
    Zhang, Dong-Zhi
    Wei, Xiao-Dong
    Wang, Xiao-Peng
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (15) : 4635 - 4643
  • [37] Liver Transplantation, Liver Resection, and Transarterial Chemoembolization for Hepatocellular Carcinoma in Cirrhosis: Which Is the Best Oncological Approach?
    Sotiropoulos, Georgios C.
    Druehe, Nina
    Sgourakis, George
    Molmenti, Ernesto P.
    Beckebaum, Susanne
    Baba, Hideo A.
    Antoch, Gerald
    Hilgard, Philip
    Radtke, Arnold
    Saner, Fuat H.
    Nadalin, Silvio
    Paul, Andreas
    Malago, Massimo
    Broelsch, Christoph E.
    Lang, Hauke
    DIGESTIVE DISEASES AND SCIENCES, 2009, 54 (10) : 2264 - 2273
  • [38] Liver resection versus chemoembolization for patients with multifocal hepatocellular carcinoma
    Zaydfudim, Victor M.
    Adams, Reid B.
    HEPATOBILIARY SURGERY AND NUTRITION, 2019, 8 (05) : 543 - 545
  • [39] Liver Transplantation, Liver Resection, and Transarterial Chemoembolization for Hepatocellular Carcinoma in Cirrhosis: Which Is the Best Oncological Approach?
    Georgios C. Sotiropoulos
    Nina Drühe
    George Sgourakis
    Ernesto P. Molmenti
    Susanne Beckebaum
    Hideo A. Baba
    Gerald Antoch
    Philip Hilgard
    Arnold Radtke
    Fuat H. Saner
    Silvio Nadalin
    Andreas Paul
    Massimo Malagó
    Christoph E. Broelsch
    Hauke Lang
    Digestive Diseases and Sciences, 2009, 54 : 2264 - 2273
  • [40] Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic patients: single center experience of 90 cases
    Ettorre, Giuseppe Maria
    Sandri, Giovanni Battista Levi
    Santoro, Roberto
    Vennarecci, Giovanni
    Lepiane, Pasquale
    Colasanti, Marco
    Felli, Emanuele
    de Werra, Edoardo
    Colace, Lidia
    D'Offizi, Gianpiero
    Montalbano, Marzia
    Visco, Ubaldo
    Maritti, Michela
    Antonini, Mario
    Santoro, Eugenio
    HEPATOBILIARY SURGERY AND NUTRITION, 2015, 4 (05) : 320 - 324